BRAFmutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions

Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients

(2015) Xinan Sheng et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

BRAF and MEK inhibition in melanoma

(2015) Lesly A Dossett et al.   Expert Opinion On Drug Safety

A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated WithBRAFMutations

(2015) Ann-Cathrine Larsen et al.   JAMA Ophthalmology

Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas

(2013) K. G. Griewank et al.   CLINICAL CANCER RESEARCH

A role for immunohistochemical detection of BRAF V600E prior to BRAF-inhibitor treatment of malignant melanoma?

(2013) Johanne Lade-Keller et al.   JOURNAL OF CLINICAL PATHOLOGY

Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma

(2012) Georgina V. Long et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

The Prognostic Value of BRAF Mutation in Colorectal Cancer and Melanoma: A Systematic Review and Meta-Analysis

(2012) Gholamreza Safaee Ardekani et al.   PLoS One

Prognostic and Clinicopathologic Associations of OncogenicBRAFin Metastatic Melanoma

(2011) Georgina V. Long et al.   JOURNAL OF CLINICAL ONCOLOGY

Conjunctival Melanoma

(2010) Carol L. Shields et al.   OPHTHALMOLOGY

Time trends in the incidence of conjunctival melanoma in Sweden

(2009) E Triay et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Genetic risk factors for melanoma

(2009) Kathrine Damm Meyle et al.   HUMAN GENETICS